Abstract
Complex biological systems constantly maintain a dynamic equilibrium (homeostasis) that is necessary for survival. This equilibrium is achieved through interactions with the environment, and adaptation to the ever-changing internal and external milieu. Throughout evolution, the stress system has remained a relatively well-preserved biological machinery that has served this function efficiently; designed to respond to internal or external challenges (stressors), and to reestablish homeostasis by various physiological and behavioral adaptive responses to stress which have been necessary for the survival of our ancestors in adverse environments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-1252.
Selye H. A syndrome produced by diverse nocuous agents. Nature. 1936;138:32-36.
Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitaryadrenocortical axis. Trends Neurosci. 1997;20(2):78-84.
Kvetnasky R, Pacak K, Sabban EL, et al. Stressor specificity of peripheral catecholaminergic activation. Adv Pharmacol. 1998;42:556-560.
Bhatnagar S, Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience. 1998;84(4):1025-1039.
Dallman MF, Bhatnagar S, Viau V. Hypothalamic-pituitary-adrenal axis. In: Fink G, ed. Encyclopedia of Stress. 1st ed. London: Academic; 2007:421-427.
Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotrophin releasing hormone perspective. Endocrinol Metab Clin North Am. 1992;21:833-858.
Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotrophin-releasing factor. Endocr Rev. 1986;7(4):351-378.
Lamberts SWJ, Verleun T, Oosterom R, et al. Corticotropin releasing factor and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab. 1984;58:298-303.
Engler O, Pham T, Fullenon MJ, et al. Studies of the secretion of corticotropin releasing factor and arginine-vasopressin into hypophyseal portal circulation of the conscious sheep. Neuroendocrinology. 1989;49:367-381.
Palkovits M, Young WS, Kovacs K, Toth ZS, Makara GB. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience. 1998;85(1):135-147.
Wong ML, Licinio J, Pasternak KI, Gold PW. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in sity hybridization histochemistry. Endocrinology. 1994;135:2275-2278.
Potter E, Sutton S, Donaldson C, et al. Distribution of corticotrophin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 1994;91(19):8777-8781.
Gray TS. Amygdala: role in autonomic and neuroendocrine responses to stress. In: McCubbin A, Kaufmann PG, Nemeroff CB, eds. Stress, Neuropeptides and Systemic Disease. New York: Academic; 1989:37-53.
Roth RH, Tam SY, Ida Y, Yang J, Deutsch AY. Stress and the mesocorticolimbic dopamine systems. Ann N Y Acad Sci. 1988;537:138-147.
Mcewen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873-904.
Dunn AJ, Berridge CW. Physiological and behavioural responses to corticotropin-releasing factor: is CRF a mediator of anxiety or stress responses? Brain Res Rev. 1990;15:71-100.
Shibasaki T, Imaki T, Hotta M, et al. Psychological stress increases arousal through brain corticotrophin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion. Brain Res. 1993;618:71-75.
Habib KE, Weld KP, Rice KC, et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA. 2000;97:6079-6084.
Smith GW, Aubry JM, Dellu F, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093-1102.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
Bailey JL, Wang X, Price SR. The balance between glucocorticoids and insulin regulates muscle proteolysis via ubiquitin-proteasome pathway. Miner Electrol Metab. 1999;25:220-223.
Breuner CW, Orchinik M. Plasma binding proteins as mediators of corticosteroid action in vertebrates. J Endocrinol. 2002;175(1):99-112.
Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711-1723.
Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev. 1996;17(3):245-261.
Lu NZ, Cidlowski JA. The origin and functions of multiple human glucocorticoid receptor isoforms. Ann N Y Acad Sci. 2004;1024:102-123.
Pujols L, Mullol J, Perez M, et al. Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Resp Cell Mol. 2001;24(1):49-57.
Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann N Y Acad Sci. 1998;851:311-335.
Chamandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259-284.
Magnuson MA, Quinn PG, Granner DK. Multihormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenicol acetyltransferase fusion genes. Insulin’s effects oppose those of cAMP and dexamethasone. J Biol Chem. 1987;262(31):14917-14920.
Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-871.
Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect “Cushing’s disease of the omentum”? Lancet. 1997;349(9060):1210-1213.
Girod JP, Brotman DJ. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res. 2004;64:217-226.
Stewart PM, Krozowski ZS. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm. 1999;57:249-324.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. JAMA. 2002;288:2709-2716.
Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329-339.
Hauner H, Schmid P, Pfeifer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 1987;64:832-835.
Ramsay TG. Fat cells. Endocrinol Metab Clin N Am. 1996;25:847-870.
Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol. 1997;79:2-9.
Mangos GJ, Walker BR, Kelly JJ, et al. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens. 2000;13:1155-1160.
Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res. 1999;41:55-64.
Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115-126.
Venihaki M, Dikkes P, Carrigan A, Karalis KP. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest. 2001;108:1159-1166.
Nikolarakis KE, Almeida OFX, Herz A. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotrophin-releasing factor. Brain Res. 1986;399:152-155.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Kaltsas, G., Zannas, A.S., Chrousos, G.P. (2011). Hypothalamic–Pituitary–Adrenal Axis and Cardiovascular Disease. In: Hjemdahl, P., Steptoe, A., Rosengren, A. (eds) Stress and Cardiovascular Disease. Springer, London. https://doi.org/10.1007/978-1-84882-419-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-84882-419-5_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-418-8
Online ISBN: 978-1-84882-419-5
eBook Packages: MedicineMedicine (R0)